Randomised phase II study to assess the efficacy and tolerability of sunitinib by dose administration regimen in anti-angiogenic naive patients with metastatic renal cell carcinoma (mRCC): Interim analysis (IA) of SURF study

Affiliation auteurs!!!! Error affiliation !!!!
TitreRandomised phase II study to assess the efficacy and tolerability of sunitinib by dose administration regimen in anti-angiogenic naive patients with metastatic renal cell carcinoma (mRCC): Interim analysis (IA) of SURF study
Type de publicationJournal Article
Year of Publication2020
AuteursThiery-Vuillemin A., Gravis G., F. Schlurmann C, Bompas E., Rolland F., Gross-Goupil M., Vano Y.A, Guillot A., Barthelemy P., Joly C., Laramas M., Dourthe L.M, Maurina T., H. Petithuguenin G, Taillandy K., Meurisse A., Vernerey D., Albiges L.
JournalANNALS OF ONCOLOGY
Volume31
PaginationS565-S566
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN0923-7534
DOI10.1016/j.annonc.2020.08.792